244 related articles for article (PubMed ID: 17420711)
1. The uncertain path to the future of imaging biomarkers.
Nunn AD
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):96-8. PubMed ID: 17420711
[No Abstract] [Full Text] [Related]
2. Nuclear medicine applications in molecular imaging: 2007 update.
Blankenberg FG; Strauss HW
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):99-110. PubMed ID: 17420712
[TBL] [Abstract][Full Text] [Related]
3. Future of nuclear medicine: SPECT versus PET.
Gholamrezanejhad A; Mirpour S; Mariani G
J Nucl Med; 2009 Jul; 50(7):16N-18N. PubMed ID: 19652221
[No Abstract] [Full Text] [Related]
4. Action plan for emerging molecular imaging technologies.
McEwan AJ; Van Brocklin HF; Divgi C
J Nucl Med; 2008 Feb; 49(2):37N-40N. PubMed ID: 18245736
[No Abstract] [Full Text] [Related]
5. Nuclear medicine 2020.
Strauss HW
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):1-3. PubMed ID: 16557198
[No Abstract] [Full Text] [Related]
6. Radiolabelled chemotherapeutics.
Rottey S; Signore A; Van de Wiele C
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):139-51. PubMed ID: 17420715
[TBL] [Abstract][Full Text] [Related]
7. SPET: sustainable, powerful, effective, timely in vivo molecular imaging.
Lucignani G
Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):117-20. PubMed ID: 16010249
[No Abstract] [Full Text] [Related]
8. Molecular imaging.
Maggi A; Salvatore M
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):95. PubMed ID: 17420710
[No Abstract] [Full Text] [Related]
9. Multimodality molecular imaging with combined optical and SPECT/PET modalities.
Culver J; Akers W; Achilefu S
J Nucl Med; 2008 Feb; 49(2):169-72. PubMed ID: 18199608
[TBL] [Abstract][Full Text] [Related]
10. Role of in vivo imaging of the central nervous system for developing novel drugs.
Rueger MA; Kracht LW; Hilker R; Thiel A; Sobesky J; Winkeler A; Thomas AV; Heneka MT; Graf R; Herholz K; Heiss WD; Jacobs AH
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):164-81. PubMed ID: 17420717
[TBL] [Abstract][Full Text] [Related]
11. Small-animal preclinical nuclear medicine instrumentation and methodology.
Rowland DJ; Cherry SR
Semin Nucl Med; 2008 May; 38(3):209-22. PubMed ID: 18396180
[TBL] [Abstract][Full Text] [Related]
12. Instrumentation and probes for molecular and cellular imaging.
Lecchi M; Ottobrini L; Martelli C; Del Sole A; Lucignani G
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):111-26. PubMed ID: 17420713
[TBL] [Abstract][Full Text] [Related]
13. [Situation of supply and boom of PET imaging: what is the future for technetium-99m in nuclear medicine?].
Maia S; Ayachi Hatit N; Paycha F
Ann Pharm Fr; 2011 May; 69(3):155-64. PubMed ID: 21570540
[TBL] [Abstract][Full Text] [Related]
14. The future of SPECT in a time of PET.
Jansen FP; Vanderheyden JL
Nucl Med Biol; 2007 Oct; 34(7):733-5. PubMed ID: 17921025
[TBL] [Abstract][Full Text] [Related]
15. How much CT is needed in nuclear medicine.
Shah C; Patton JA; Sandler MP
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1759-60. PubMed ID: 18542958
[No Abstract] [Full Text] [Related]
16. [Molecular imaging with positron emission tomography and single photon emission computer tomography. Status and perspectives].
Kjaer A
Ugeskr Laeger; 2005 Nov; 167(48):4549-52. PubMed ID: 16324434
[TBL] [Abstract][Full Text] [Related]
17. Multimodality imaging: novel pharmacological applications of reporter systems.
Stell A; Belcredito S; Ramachandran B; Biserni A; Rando G; Ciana P; Maggi A
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):127-38. PubMed ID: 17420714
[TBL] [Abstract][Full Text] [Related]
18. Imaging biomarkers, an industry perspective.
Nunn A
J Nucl Med; 2008 Jun; 49(6):28N-32N. PubMed ID: 18511817
[No Abstract] [Full Text] [Related]
19. Evaluating pathology in the brain with nuclear medicine.
Silverman DH
Semin Nucl Med; 2008 Jul; 38(4):225-6. PubMed ID: 18514078
[No Abstract] [Full Text] [Related]
20. Collaborations in the development and validation of imaging biomarkers.
Sullivan D
J Nucl Med; 2008 Jun; 49(6):36N-37N. PubMed ID: 18511820
[No Abstract] [Full Text] [Related]
[Next] [New Search]
